口腔颌面部骨质疏松的药物治疗研究

目的口腔颌面部骨骼作为全身骨骼的一部分,影响全身骨质疏松的因素同样也可影响颌骨.对全身骨质疏松有治疗作用的药物对口腔颌面部骨骼的作用如何,目前已成为研究热点.文章回顾了目前已作用于颌骨、牙槽骨骨质疏松动物实验及临床的药物研究,寻找口腔颌面部骨质疏松的药物治疗方法.资料来源应用计算机检索Medline数据库1990-01/2001-10的相关文章,检索词"Osteoporosis,mandible,bisphosphonates,herb,estradiol,",并限定语言种类分别为English,同时计算机检索中国期刊全文数据库1995-01/2003-12的相关文章,检索词"骨质疏松,下颌骨,磷酸盐,雌激素,草药."资料选择对资料进行初审,选取包括上述治疗组和对照组和文献,然后筛除非随机的试验研究和重复研究,对剩余的文献开始查找全文,以随机对照(RCT)作为纳入标准.资料提炼共收集到17篇关于药物治疗口腔颌面部骨质疏松的随机试验,13篇符合纳入标准,排除4篇重复研究.资料综合17个试验的对象均为符合诊断标准的骨质疏松症患者,治疗选用抑制骨吸引的药物、增加骨量的药物以及改善骨质量的药物,从骨密度、骨量、骨强度等方面对药物的疗效进行了对照研究及相关分析.结论针对全身骨质疏松治疗的药物能有效改善颌骨骨质结构,减缓牙槽骨吸收,促进新骨形成.

Medicines for maxillofacial osteoporosis

OBJECTIVE: Factors that result in systemic osteoporosis will also affect maxillofacial bones for the latter is a component of skeleton. Present studies are being focused on how is the effect of the drugs that are used to treat systemic osteoporosis on maxillofacial bones. In this article we reviewedclinical and experimental studies about the drugs that acts on maxillomandibular and alveolar bone loss in order to find treatment for maxillofacial bone loss.DATA SOURCES: Medline was searched from January 1999 to October 2001 for English literatures with the searching words of "osteoporosis,mandible, bisphosphonates, herb, estradiol." And Chinese journal database was also searched from January 1995 to December 2004 for Chinese literatures with the searching words of "osteoporosis, mandible, bisphosphonates,herb estradiol"DATA SELECTION: The literatures of therapeutic and controlled studies were chosen, from which the non-random trials and repeated ones were excluded. The full texts of the remaining literatures were found and those of random and controlled trials were included in this review.DATA EXTRACTION: Seventeen literatures that were about random trials on the treatment of maxillofacial bone loss were collected. Thirteen of these 17 were included in this review and 4 of repeated trials were excluded.DATA SYNTHESIS: The subjects in the 17 literatures were all patients with osteoporosis that were in compatible with diagnosis standard. Drugs that act by inhibiting bone resorption, increasing bone mass and ameliorating bone quality were used. The effects of the drugs were compared and analyzed in perspective of the density, mass and strength of bone.CONCLUSION: Medicines for systemic osteoporosis are effective in ameliorating maxillomandibular bone structure, delaying alveolar bone resorption and promoting new bone formation.